Contaminated Cough syrup tragedy: Sresen Pharma owner remanded in 10-day police custody

Written By :  Ruchika Sharma
Published On 2025-10-11 08:22 GMT   |   Update On 2025-10-11 08:22 GMT
Advertisement

Chhindwara: The owner of a Tamil Nadu-based pharma company, Sresen Pharma, was remanded in 10-day police custody by a court on Friday after being linked to the tragic deaths of over 20 children in Madhya Pradesh.

Ranganathan Govindan, whose company manufactured the contaminated Coldrif cough syrup, was arrested by a Special Investigative Team (SIT) set up by the MP government.

Govindan was brought before Additional Session Judge Gautam Gurjar in Parasia town after he was brought on transit remand from a Chennai court, SIT chief Jitendra Jaat said.

Advertisement

The court has remanded Ranganathan Govindan in 10-day police remand, Jaat told PTI. Additional collector Dhirendra Singh Netri maintained that so far 22 children have died because of "contaminated" Coldrif syrup.

These children, from Chhindwara and other districts, died due to suspected kidney failure, which is linked to the consumption of 'toxic' Coldrif cough syrup, as per officials, adding that some children from the state are undergoing treatment in Nagpur in neighbouring Maharashtra. The factory in which the cough syrup was manufactured has been sealed, Jaat added.

In action related to the episode, which has made national headlines, the Mohan Yadav government earlier this week suspended two drug inspectors and a deputy director of the Food and Drug Administration (FDA).

It also transferred the state's drug controller amid an investigation into the children's deaths, while police arrested Chhindwara-based Dr Praveen Soni for alleged negligence. Soni's bail plea was rejected on Wednesday by a court in Parasia. Incidentally, the Indian Medical Association has opposed the arrest of Dr Soni and its members have sported black bands in protest.

Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News